arrears. The following table provides a summary of the Company’s term debt as of September 25, 2021 and September 26,
2020:
Maturities
(calendar year)
2021 2020
Amount
(in millions)
Effective
Interest Rate
Amount
(in millions)
Effective
Interest Rate
2013 – 2020 debt issuances:
Floating-rate notes 2022 $ 1,750 0.48% – 0.63% $ 2,250 0.60% – 1.39%
Fixed-rate 0.000% – 4.650% notes 2022 – 2060 95,813 0.03% – 4.78% 103,828 0.03% – 4.78%
Second quarter 2021 debt issuance:
Fixed-rate 0.700% – 2.800% notes 2026 – 2061 14,000 0.75% – 2.81% —  — %
Fourth quarter 2021 debt issuance:
Fixed-rate 1.400% – 2.850% notes 2028 – 2061 6,500 1.43% – 2.86% —  — %
Total term debt 118,063  106,078
Unamortized premium/(discount) and issuance
costs, net (380)  (314)
Hedge accounting fair value adjustments 1,036  1,676
Less: Current portion of term debt (9,613)  (8,773)
Total non-current portion of term debt $ 109,106 $ 98,667
To manage interest rate risk on certain of its U.S. dollar–denominated fixed- or floating-rate notes, the Company has entered into
interest rate swaps to effectively convert the fixed interest rates to floating interest rates or the floating interest rates to fixed
interest rates on a portion of these notes. Additionally, to manage foreign currency risk on certain of its foreign currency–
denominated notes, the Company has entered into foreign currency swaps to effectively convert these notes to U.S. dollar–
denominated notes.
The effective interest rates for the Notes include the interest on the Notes, amortization of the discount or premium and, if
applicable, adjustments related to hedging. The Company recognized $2.6 billion, $2.8 billion and $3.2 billion of interest expense
on its term debt for 2021, 2020 and 2019, respectively.
The future principal payments for the Company’s Notes as of September 25, 2021, are as follows (in millions):
2022 $ 9,583
2023 11,391
2024 10,202
2025 10,914
2026 11,408
Thereafter 64,565
Total term debt $ 118,063
As of September 25, 2021 and September 26, 2020, the fair value of the Company’s Notes, based on Level 2 inputs, was $125.3
billion and $117.1 billion, respectively.
Apple Inc. | 2021 Form 10-K | 45Note 8 – Shareholders’ Equity
Share Repurchase Program
As of September 25, 2021, the Company was authorized to purchase up to $315 billion of the Company’s common stock under a
share repurchase program (the “Program”). During 2021, the Company repurchased 656 million shares of its common stock for
$85.5 billion, including 36 million shares delivered under a $5.0 billion accelerated share repurchase agreement entered into in
May 2021, bringing the total utilization under the Program to $254.1 billion as of September 25, 2021. The Program does not
obligate the Company to acquire any specific number of shares. Under the Program, shares may be repurchased in privately
negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”).
Shares of Common Stock
The following table shows the changes in shares of common stock for 2021, 2020 and 2019 (in thousands):
2021 2020 2019
Common stock outstanding, beginning balances 16,976,763  17,772,945  19,019,943
Common stock repurchased (656,340)  (917,270)  (1,380,819)
Common stock issued, net of shares withheld for employee taxes 106,363  121,088  133,821
Common stock outstanding, ending balances 16,426,786  16,976,763  17,772,945
Note 9 – Benefit Plans 2014 Employee Stock Plan
The 2014 Employee Stock Plan (the “2014 Plan”) is a shareholder-approved plan that provides for broad-based equity grants to
employees, including executive officers, and permits the granting of restricted stock units (“RSUs”), stock grants, performance-
based awards, stock options and stock appreciation rights, as well as cash bonus awards. RSUs granted under the 2014 Plan
